Cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma: A pilot study

Journal of veterinary internal medicine / American College of Veterinary Internal Medicine

Volumn 14, Issue 5, 2000, Pages 495-498

  Chun, Ruthanne ^a   Kurzman, Ilene D ^b   Couto, C Guillermo ^c   Klausner, Jeff ^d   Henry, Carolyn ^e   MacEwen, E Gregory ^b  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN;

AMPUTATION; ANIMAL; ANIMAL DISEASE; ARTICLE; BONE TUMOR; DISEASE FREE SURVIVAL; DOG; DOG DISEASE; FEMUR; HUMERUS; LUNG TUMOR; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PILOT STUDY; PROPORTIONAL HAZARDS MODEL; RADIUS; RANDOMIZATION; STANDARD; THORAX RADIOGRAPHY; TIBIA;

AMPUTATION; ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; DOXORUBICIN; FEMUR; HUMERUS; LUNG NEOPLASMS; OSTEOSARCOMA; PILOT PROJECTS; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHY, THORACIC; RADIUS; RANDOM ALLOCATION; TIBIA;

EID: 0034276725     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2000.tb02265.x     Document Type: Article

References (21)

1. 1 Straw RC, Withrow SJ, Richter SL, et al. Amputation and cisplatin for treatment of canine osteosarcoma. J Vet Intern Med 1991 ; 5: 205–210.
2. 2 Thompson JP, Fugent MJ. Evaluation of survival times after limb amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979— 1990). J Am Vet Med Assoc 1992 ; 20: 531–533.
3. 3 Bergman PJ, MacEwen EG, Kurzman ID, et al. Amputation and carboplatin for treatment of dogs with osteosarcoma: 48 cases (1991–1993). J Vet Intern Med 1996 ; 10: 76–81.
4. 4 Spodnick GJ, Berg J., Rand WM, et al. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978–1988). J Am Vet Med Assoc 1992 ; 200: 995–999.
5. 5 Ogilvie GK, Straw RC, Jameson VJ, et al. Evaluation of single‐agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987–1991). J Am Vet Med Assoc 1993 ; 202: 304–306.
6. 6 Shapiro W., Fossum TW, Kitchell BE, et al. Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 1988 ; 192: 507–511.
7. 7 Kurzman ID, MacEwen EG, Rosenthal RC, et al. Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome‐encapsulated muramyl tripeptide and cisplatin. Clin Cancer Res 1995 ; 1: 1595–1601.
8. 8 Berg J., Weinstein MJ, Schelling SH, et al. Treatment of dogs with osteosarcoma by administration of cisplatin after amputation or limb‐sparing surgery: 22 cases (1987–1990). J Am Vet Med Assoc 1992 ; 200: 2005–2008.
9. 9 Kraegel SA, Madewell BR, Simonson E., et al. Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986–1989). J Am Vet Med Assoc 1991 ; 199: 1057–1059.
10. 10 Berg J., Weinstein MJ, Springfield DS, et al. Results of surgery and doxorubicin chemotherapy in dogs with osteosarcoma. J Am Vet Med Assoc 1995 ; 206: 1555–1560.
11. 11 Mauldin GN, Matus RE, Withrow SJ, et al. Canine osteosarcoma. Treatment by amputation versus amputation and adjuvant chemotherapy using doxorubicin and cisplatin. J Vet Intern Med 1988 ; 2: 177–180.
12. 12 Ogilvie GK, Reynolds HA, Richardson RC, et al. Phase II evaluation of doxorubicin for treatment of various canine neoplasms. J Am Vet Med Assoc 1989 ; 195: 1580–1583.
13. 13 Madewell BR, Leighton RL, Theilen GH. Amputation and doxorubicin for treatment of canine and feline osteogenic sarcoma. Eur J Cancer 1978 ; 14: 287–293.
14. 14 DeVita VT. Principles of chemotherapy. In: DeVita VT, Hell‐man S., Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia, PA: JB Lippincott Co ; 1993: 276–292.
15. 15 Chabner BA. Clinical strategies for cancer treatment: the role of drugs. In: Chabner BA, Collins JM, eds. Cancer Chemotherapy Principles and Practice. Philadelphia, PA: JB Lippincott Co ; 1990: 1–15.
16. 16 Ogilvie GK, Krawiec DR, Gelberg HB, et al. Evaluation of a short‐term saline diuresis protocol for the administration of cisplatin. Am J Vet Res 1988 ; 49: 1076–1078.
17. 17 Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statis Assoc 1958 ; 53: 457–462.
18. 18 Breslow N. A generalized Kruskal‐Wallis test for comparing samples subject to unequal patterns of censorship. Biometrika 1970 ; 57: 579–583.
19. 19 Cox DR. Regression models and life tables. J Roy Statis Soc 1972 ; series B: 187–190.
20. 20 Shi F., MacEwen EG, Kurzman ID. In vitro and in vivo effect of doxorubicin combined with liposome‐encapsulated muramyl tripeptide on canine monocyte activation. Cancer Res 1993 ; 53: 3986–3991.
21. 21 MacEwen EG, Kurzman ID, Rosenthal RC, et al. Therapy for osteosarcoma in dogs with intravenous injection of liposome‐encapsulated muramyl tripeptide. J Natl Cancer Inst 1989 ; 81: 935–938.